Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing ...
Expected to extend cash runway into the second quarter of 2027, supporting additional follow-up for 2L+ R/M HNSCC patients treated with MICVO at or below a dose cap ...
This library serves as a comprehensive reference implementation of MessagePack for JavaScript with a focus on accuracy, compatibility, interoperability, and performance. Additionally, this is also a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results